221 related articles for article (PubMed ID: 32413098)
1. Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice.
Ceyhan Y; Zhang M; Guo J; Sandoval CG; Vacher J; Kaftanovskaya EM; Agoulnik AI; Agoulnik IU
PLoS One; 2020; 15(5):e0233163. PubMed ID: 32413098
[TBL] [Abstract][Full Text] [Related]
2. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
[TBL] [Abstract][Full Text] [Related]
3. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
4. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.
Zhang M; Suarez E; Vasquez JL; Nathanson L; Peterson LE; Rajapakshe K; Basil P; Weigel NL; Coarfa C; Agoulnik IU
Oncogene; 2019 Feb; 38(7):1121-1135. PubMed ID: 30228349
[TBL] [Abstract][Full Text] [Related]
5. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
Hodgson MC; Shao LJ; Frolov A; Li R; Peterson LE; Ayala G; Ittmann MM; Weigel NL; Agoulnik IU
Cancer Res; 2011 Jan; 71(2):572-82. PubMed ID: 21224358
[TBL] [Abstract][Full Text] [Related]
8. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC
Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222
[TBL] [Abstract][Full Text] [Related]
9. INPP4B: the new kid on the PI3K block.
Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
[TBL] [Abstract][Full Text] [Related]
11. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
[TBL] [Abstract][Full Text] [Related]
12. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
13. Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities.
Lopez SM; Hodgson MC; Packianathan C; Bingol-Ozakpinar O; Uras F; Rosen BP; Agoulnik IU
Biochem Biophys Res Commun; 2013 Oct; 440(2):277-82. PubMed ID: 24070612
[TBL] [Abstract][Full Text] [Related]
14. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
[TBL] [Abstract][Full Text] [Related]
15. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W
J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642
[TBL] [Abstract][Full Text] [Related]
16. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Ding H; Sun Y; Hou Y; Li L
Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
[TBL] [Abstract][Full Text] [Related]
17. INPP4B protects from metabolic syndrome and associated disorders.
Zhang M; Ceyhan Y; Kaftanovskaya EM; Vasquez JL; Vacher J; Knop FK; Nathanson L; Agoulnik AI; Ittmann MM; Agoulnik IU
Commun Biol; 2021 Mar; 4(1):416. PubMed ID: 33772116
[TBL] [Abstract][Full Text] [Related]
18. Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells.
Kim JS; Yun HS; Um HD; Park JK; Lee KH; Kang CM; Lee SJ; Hwang SG
Cancer Biol Ther; 2012 Nov; 13(13):1307-18. PubMed ID: 22895072
[TBL] [Abstract][Full Text] [Related]
19. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
20. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]